University of Minnesota. Driven to Discover.
(CIDRAP News) – The latest trial of the world's first malaria vaccine showed it was only modestly beneficial in African infants, a somewhat disappointing finding after an earlier part of the study showed that it halved cases in older babies.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.